Evidence map›Paper›PMID 27020708›Full record

ArticleThe Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases

Hepatitis E virus seroprevalence among schistosomiasis patients in Northeastern Brazil.

Ana Maria Passos-Castilho, Anne de Sena, Ana Lucia Coutinho Domingues, Edmundo Pessoa Lopes-Neto, Tibério Batista Medeiros, Celso Francisco Hernandez Granato, Maria Lúcia Ferraz

Open access · goldAbstract read
In one paragraph

Article in The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Seroprevalence of hepatitis E virus in patients with chronic liver disease.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ana Maria Passos-CastilhoDivision of Infectious Diseases, Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil.
Anne de SenaDivision of Infectious Diseases, Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil; Fleury SA Group, Brazil.
Ana Lucia Coutinho DominguesDivision of Gastroenterology, Universidade Federal de Pernambuco (UFPE), Recife, PE, Brazil.
Edmundo Pessoa Lopes-NetoDivision of Gastroenterology, Universidade Federal de Pernambuco (UFPE), Recife, PE, Brazil.
Tibério Batista MedeirosDivision of Gastroenterology, Universidade Federal de Pernambuco (UFPE), Recife, PE, Brazil.
Celso Francisco Hernandez GranatoDivision of Infectious Diseases, Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil; Fleury SA Group, Brazil.
Maria Lúcia FerrazDivision of Gastroenterology, Universidade Federal de São Paulo (Unifesp), São Paulo, Brazil. Electronic address: marialucia.ferraz@uol.com.br.
Universidade Federal de Pernambuco · BRFleury S.A. (Brazil) · BRUniversidade Federal de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHepatitis E virus (HEV) can cause chronic infection with rapid progression to liver cirrhosis in immunocompromised patients. HEV seroprevalence in patients with Schistosoma mansoni in Brazil is unknown. We evaluated the prevalence of past or present HEV infection in schistosomiasis patients in Recife, Pernambuco, Brazil. A total of 80 patients with Schistosoma mansoni were consecutively enrolled in a cross-sectional study. Serum samples were tested for the presence of anti-HEV IgG antibodies by enzyme immunoassay (Wantai anti-HEV IgG, Beijing, China) and for the presence of HEV RNA using real time reverse transcriptase-polymerase chain reaction with primers targeting the HEV ORF2 and ORF3. Clinical and laboratory tests as well as abdominal ultrasound were performed at the same day of blood collection.

resultsAnti-HEV IgG was positive in 18.8% (15/80) of patients with SM. None of the samples tested positive for anti-HEV IgM or HEV-RNA. Patients with anti-HEV IgG positive presented higher levels of alanine aminotranferase (p=0.048) and gama-glutamil transferase (p=0.022) when compared to patients without anti-HEV IgG antibodies.

conclusionThis study demonstrates that the seroprevalence of HEV is high in patients with Schistosoma mansoni in Northeastern of Brazil. Past HEV infection is associated with higher frequency of liver enzymes abnormalities. HEV infection and its role on the severity of liver disease should be further investigated among patients with Schistosoma mansoni.

Indexed as

AdolescentAdultAgedAnimalsBrazilCross-Sectional StudiesFemaleHepatitis AntibodiesHepatitis EHepatitis E virusHumansImmunoglobulin GImmunoglobulin MMaleMiddle AgedPrevalenceHepatitis AntibodiesImmunoglobulin GImmunoglobulin MBrazilEpidemiologyHepatitis E virusSchistosomiasisSeroprevalence

Identifiers

PMID27020708
PMCPMC9425348
OpenAlexW2306611430

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.